Psoriasis trials in China

In China 49 Also abroad 274

49 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.

No phaseNot yet taking people in China
Research on the Extraction of Tongue and Facial Diagnosis Features of Psoriasis Vulgaris in Traditional Chinese Medicine and Its Correlation With Laboratory Indicators
Where
Shanghai
Age
18 years to 65 years
People
450
Run by
Shanghai Yueyang Integrated Medicine Hospital
See details and how to joinNCT07351448
Phase 2Taking people
Efficacy and Safety of ICP-332 Versus Placebo in Participants With Moderate to Severe Plaque Psoriasis
Where
Shanghai
Age
18 years to 70 years
People
172
Run by
Beijing InnoCare Pharma Tech Co., Ltd.
See details and how to joinNCT07251998
Phase 2Taking people
Safety and Efficacy of Lactobacillus Plantarum for Psoriasis: A Randomized Double-Blind Placebo-Controlled Trial
Where
Shenzhen
Age
16 years to 60 years
People
184
Run by
Shenzhen People's Hospital
See details and how to joinNCT07194200
Phase 3Taking people
A Study to Evaluate Efficacy and Safety of IBI112 in Adolescent Participants With Moderate to Severe Plaque Psoriasis
Where
Beijing
Age
12 years to 18 years
People
104
Run by
Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.
See details and how to joinNCT07265284
Phase 3Taking people
Evaluate the Efficacy and Safety of D-2570 in Subjects With Moderate to Severe Plaque Psoriasis
Where
Beijing
Age
18 years to 70 years
People
390
Run by
InventisBio Co., Ltd
See details and how to joinNCT07130604
Phase 1Taking people
To Evaluate the Pharmacokinetics of Hemay005 Tablets in Subjects With Liver Damage
Where
Wuhan
Age
18 years to 70 years
People
24
Run by
Ganzhou Hemay Pharmaceutical Co., Ltd
See details and how to joinNCT06376474
No phaseTaking people
A Study to Evaluate Effectiveness and Safety of a TYK2 Inhibitor in Subjects With Moderate to Severe Plaque Psoriasis
Where
Shanghai
Age
18 years to 70 years
People
140
Run by
Usynova Pharmaceuticals Ltd.
See details and how to joinNCT07234591
Phase 1Taking people
A Study of UA026 Tablets in Healthy Adult Subjects and Adult Subjects With Moderate to Severe Plaque Psoriasis
Where
Hangzhou
Age
18 years to 55 years
People
124
Run by
Usynova Pharmaceuticals Ltd.
See details and how to joinNCT07038720
Phase 2Not yet taking people in China
A Phase II Efficacy and Safety Study of HSK44459 in Subjects With Moderate to Severe Plaque Psoriasis
Where
Hangzhou
Age
18 years and over
People
150
Run by
Haisco Pharmaceutical Group Co., Ltd.
See details and how to joinNCT07150988
Phase 2Not yet taking people in China
A Clinical Study to Evaluate the Safety and Pharmacokinetics of Topical RSS0393 Ointment in Children and Adolescents With Plaque Psoriasis
Where
Beijing
Age
6 years to 17 years
People
20
Run by
Jiangsu HengRui Medicine Co., Ltd.
See details and how to joinNCT07102888
Phase 1Taking people
Evaluate the Safety and Pharmacokinetics/Pharmacodynamics and Food Effect of HS-20118
Where
Hangzhou
Age
18 years to 65 years
People
142
Run by
Jiangsu Hansoh Pharmaceutical Co., Ltd.
See details and how to joinNCT07033234
No phaseTaking people
A Prospective Study to Assess the Efficacy of IL-17 Inhibitors on Subclinical Enthesitis in Patients With Moderate to Severe Psoriasis Based on Power Doppler (PD) Ultrasonography (PDUS)
Where
Nanjing
Age
18 years and over
People
50
Run by
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
See details and how to joinNCT06987292
Phase 3Enrolling by invitation
Sulodexide in Controlling the Recurrence of Psoriasis
Where
Xi'an
Age
18 years to 65 years
People
160
Run by
Xijing Hospital
See details and how to joinNCT06982196
No phaseTaking people
Phase IV Study: Vunakizumab Efficacy and Safety in Moderate-to-severe Plaque Psoriasis
Where
Shenyang
Age
18 years and over
People
1,516
Run by
First Hospital of China Medical University
See details and how to joinNCT06696417
Phase 2Not yet taking people in China
A Study to Evaluate Efficacy and Safety of HS-10374 for Mild-to-moderate Plaque Psoriasis
Where
Shanghai
Age
18 years to 70 years
People
305
Run by
Hansoh BioMedical R&D Company
See details and how to joinNCT06926582
Phase 2Taking people
A Study of WD-890 in Participants With Moderate-to-Severe Plaque Psoriasis
Where
Nanjing
Age
18 years to 70 years
People
140
Run by
Zhejiang Wenda Pharma Technology LTD.
See details and how to joinNCT06912165
Phase 2Taking people
Efficacy and Safety of HB0034 in Patients with Generalized Pustular Psoriasis (GPP)
Where
Beijing, Shanghai
Age
18 years to 75 years
People
33
Run by
Shanghai Huaota Biopharmaceutical Co., Ltd.
See details and how to joinNCT06231381
Phase 3Not yet taking people in China
The Efficacy and Safety of SHR-1314 in the Treatment of Pediatric Patients of Age 6 to <18 Years With Moderate to Severe Plaque Psoriasis
Where
Beijing, Shanghai
Age
6 years to 18 years
People
90
Run by
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
See details and how to joinNCT06833307
No phaseNot yet taking people in China
Real-World Study of Xeligekimab for Moderate to Severe Plaque Psoriasis(XP-Real)
Where
Hunan
Age
18 years and over
People
1,000
Run by
Chongqing Genrix Biopharmaceutical Co., Ltd
See details and how to joinNCT06802848
Phase 4Not yet taking people in China
Phase IV Study: Vunakizumab Efficacy and Safety in Moderate-to-severe Plaque Psoriasis
Where
Beijing
Age
18 years and over
People
1,564
Run by
Suzhou Suncadia Biopharmaceuticals Co., Ltd.
See details and how to joinNCT06779097
No phaseNot yet taking people in China
A Registry Study Assessing PRO, Dosing Patterns, and Safety of Vunakizumab in Patients With General Rheumatic Diseases.
Where
Hangzhou
Age
18 years and over
People
10,000
Run by
Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT06766552
No phaseTaking people
Prospective Study of Classification and Activity Assessment of Psoriatic Arthritis Based on Power Doppler (PD) Ultrasonography (PDUS)
Where
Nanjing
Age
18 years and over
People
400
Run by
Nanjing Medical University
See details and how to joinNCT06730334
No phaseTaking people
Immunoclassification of Psoriasis: a Strategy for Precision Medicine
Where
Hangzhou
Age
18 years to 75 years
People
100
Run by
Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT05503875
No phaseTaking people
Chinese Psoriasis Real World Evidence Research
Where
Beijing, Chongqing, Fujian, Gansu, Guangdong, Guangxi, Guizhou, Hainan, Hangzhou, Hebei, Heilongjiang, Henan, Hohhot, Hubei, Hunan, Jiangxi, Jilin City, Nanjing, Qinghai, Shandong, Shanghai, Shanxi, Shenyang, Sichuan, Tianjin, Xinjiang, Yinchuan, Yunnan
People
10,000
Run by
Second Affiliated Hospital, Zhejiang University, School of Medicine
See details and how to joinNCT04465838